Faron Pharmaceuticals Oy (LON:FARN) Stock Price Passes Above Fifty Day Moving Average – Should You Sell?

Faron Pharmaceuticals Oy (LON:FARN)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 176.23 ($2.28) and traded as high as GBX 220 ($2.85). Faron Pharmaceuticals Oy shares last traded at GBX 202.75 ($2.62), with a volume of 25,650 shares trading hands.

Faron Pharmaceuticals Oy Stock Down 3.5 %

The company has a market cap of £272.20 million, a P/E ratio of -5.42 and a beta of 0.36. The company has a current ratio of 1.45, a quick ratio of 1.09 and a debt-to-equity ratio of 922.55. The firm’s 50 day moving average price is GBX 176.23 and its 200-day moving average price is GBX 185.01.

About Faron Pharmaceuticals Oy

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.